EU5 IVD Analyzers Market Outlook to 2033: Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995

GlobalData’s “EU5 IVD Analyzers Market Outlook to 2033” is a comprehensive databook report, covering key market data on the EU5 IVD Analyzers market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers, Clinical Chemistry Analyzers, Integrated Clinical Chemistry & Immunochemistry Analyzers, Immunochemistry Analyzers and Next Generation Sequencers

The EU5 IVD Analyzers Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for IVD Analyzers Market.
• Global corporate-level profiles of key companies operating within the EU5 IVD Analyzers Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

EU5 IVD Analyzers is segmented as follows –

• Hematology Analyzers

• Polymerase Chain Reaction (PCR) Systems

• Point of Care (POC) Analyzers

• Clinical Chemistry Analyzers

• Integrated Clinical Chemistry & Immunochemistry Analyzers

• Immunochemistry Analyzers

• Next Generation Sequencers

Reasons to Buy

The EU5 IVD Analyzers Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 8

2 Introduction 10

2.1 What Is This Report About? 10

2.2 IVD Analyzers Market Segmentation 10

2.3 Definitions of Markets Covered in the Report 11

3 IVD Analyzers Market, EU5 15

3.1 IVD Analyzers Market, EU5, Revenue ($m), 2018-2033 15

3.2 IVD Analyzers Market, EU5, Revenue ($m), 2018-2033 16

3.3 IVD Analyzers Market, EU5, Volume (Units), 2018-2033 19

3.4 IVD Analyzers Market, EU5, Volume (Units), 2018-2033 20

3.5 IVD Analyzers Market, EU5, Company Share by Revenue ($m), 2024 22

4 IVD Analyzers Market, United Kingdom 24

4.1 IVD Analyzers Market, United Kingdom, Revenue ($m), 2018-2033 24

4.1.1 Clinical Chemistry Analyzers Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 26

4.1.2 Hematology Analyzers Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 28

4.1.3 Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 30

4.1.4 Next Generation Sequencers Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 32

4.1.5 Point of Care (POC) Analyzers Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 34

4.1.6 Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 36

4.2 IVD Analyzers Market, United Kingdom, Volume (Units), 2018-2033 38

4.2.1 Clinical Chemistry Analyzers Market, United Kingdom, Volume (Units), by Segment, 2018-2033 41

4.2.2 Hematology Analyzers Market, United Kingdom, Volume (Units), by Segment, 2018-2033 43

4.2.3 Immunochemistry Analyzers Market, United Kingdom, Volume (Units), by Segment, 2018-2033 45

4.2.4 Next Generation Sequencers Market, United Kingdom, Volume (Units), by Segment, 2018-2033 47

4.2.5 Point of Care (POC) Analyzers Market, United Kingdom, Volume (Units), by Segment, 2018-2033 49

4.2.6 Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Volume (Units), by Segment, 2018-2033 51

4.3 IVD Analyzers Market, United Kingdom, Average Price ($) , 2018-2033 53

4.4 IVD Analyzers Market, United Kingdom, Company Share by Revenue ($m), 2024 56

5 IVD Analyzers Market, Germany 58

5.1 IVD Analyzers Market, Germany, Revenue ($m), 2018-2033 58

5.1.1 Clinical Chemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2018-2033 60

5.1.2 Hematology Analyzers Market, Germany, Revenue ($m), by Segment, 2018-2033 62

5.1.3 Immunochemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2018-2033 64

5.1.4 Next Generation Sequencers Market, Germany, Revenue ($m), by Segment, 2018-2033 66

5.1.5 Point of Care (POC) Analyzers Market, Germany, Revenue ($m), by Segment, 2018-2033 68

5.1.6 Polymerase Chain Reaction (PCR) Systems Market, Germany, Revenue ($m), by Segment, 2018-2033 70

5.2 IVD Analyzers Market, Germany, Volume (Units), 2018-2033 72

5.2.1 Clinical Chemistry Analyzers Market, Germany, Volume (Units), by Segment, 2018-2033 75

5.2.2 Hematology Analyzers Market, Germany, Volume (Units), by Segment, 2018-2033 77

5.2.3 Immunochemistry Analyzers Market, Germany, Volume (Units), by Segment, 2018-2033 79

5.2.4 Next Generation Sequencers Market, Germany, Volume (Units), by Segment, 2018-2033 81

5.2.5 Point of Care (POC) Analyzers Market, Germany, Volume (Units), by Segment, 2018-2033 83

5.2.6 Polymerase Chain Reaction (PCR) Systems Market, Germany, Volume (Units), by Segment, 2018-2033 85

5.3 IVD Analyzers Market, Germany, Average Price ($) , 2018-2033 87

5.4 IVD Analyzers Market, Germany, Company Share by Revenue ($m), 2024 90

6 IVD Analyzers Market, France 92

6.1 IVD Analyzers Market, France, Revenue ($m), 2018-2033 92

6.1.1 Clinical Chemistry Analyzers Market, France, Revenue ($m), by Segment, 2018-2033 94

6.1.2 Hematology Analyzers Market, France, Revenue ($m), by Segment, 2018-2033 96

6.1.3 Immunochemistry Analyzers Market, France, Revenue ($m), by Segment, 2018-2033 98

6.1.4 Point of Care (POC) Analyzers Market, France, Revenue ($m), by Segment, 2018-2033 100

6.1.5 Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), by Segment, 2018-2033 102

6.2 IVD Analyzers Market, France, Volume (Units), 2018-2033 104

6.2.1 Clinical Chemistry Analyzers Market, France, Volume (Units), by Segment, 2018-2033 106

6.2.2 Hematology Analyzers Market, France, Volume (Units), by Segment, 2018-2033 108

6.2.3 Immunochemistry Analyzers Market, France, Volume (Units), by Segment, 2018-2033 110

6.2.4 Point of Care (POC) Analyzers Market, France, Volume (Units), by Segment, 2018-2033 112

6.2.5 Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), by Segment, 2018-2033 114

6.3 IVD Analyzers Market, France, Average Price ($), 2018-2033 116

6.4 IVD Analyzers Market, France, Company Share by Revenue ($m), 2024 119

7 IVD Analyzers Market, Italy 121

7.1 IVD Analyzers Market, Italy, Revenue ($m), 2018-2033 121

7.1.1 Clinical Chemistry Analyzers Market, Italy, Revenue ($m), by Segment, 2018-2033 123

7.1.2 Hematology Analyzers Market, Italy, Revenue ($m), by Segment, 2018-2033 125

7.1.3 Immunochemistry Analyzers Market, Italy, Revenue ($m), by Segment, 2018-2033 127

7.1.4 Point of Care (POC) Analyzers Market, Italy, Revenue ($m), by Segment, 2018-2033 129

7.1.5 Polymerase Chain Reaction (PCR) Systems Market, Italy, Revenue ($m), by Segment, 2018-2033 131

7.2 IVD Analyzers Market, Italy, Volume (Units), 2018-2033 133

7.2.1 Clinical Chemistry Analyzers Market, Italy, Volume (Units), by Segment, 2018-2033 135

7.2.2 Hematology Analyzers Market, Italy, Volume (Units), by Segment, 2018-2033 137

7.2.3 Immunochemistry Analyzers Market, Italy, Volume (Units), by Segment, 2018-2033 139

7.2.4 Point of Care (POC) Analyzers Market, Italy, Volume (Units), by Segment, 2018-2033 141

7.2.5 Polymerase Chain Reaction (PCR) Systems Market, Italy, Volume (Units), by Segment, 2018-2033 143

7.3 IVD Analyzers Market, Italy, Average Price ($), 2018-2033 145

7.4 IVD Analyzers Market, Italy, Company Share by Revenue ($m), 2024 148

8 IVD Analyzers Market, Spain 150

8.1 IVD Analyzers Market, Spain, Revenue ($m), 2018-2033 150

8.1.1 Clinical Chemistry Analyzers Market, Spain, Revenue ($m), by Segment, 2018-2033 152

8.1.2 Hematology Analyzers Market, Spain, Revenue ($m), by Segment, 2018-2033 154

8.1.3 Immunochemistry Analyzers Market, Spain, Revenue ($m), by Segment, 2018-2033 156

8.1.4 Point of Care (POC) Analyzers Market, Spain, Revenue ($m), by Segment, 2018-2033 158

8.1.5 Polymerase Chain Reaction (PCR) Systems Market, Spain, Revenue ($m), by Segment, 2018-2033 160

8.2 IVD Analyzers Market, Spain, Volume (Units), 2018-2033 162

8.2.1 Clinical Chemistry Analyzers Market, Spain, Volume (Units), by Segment, 2018-2033 164

8.2.2 Hematology Analyzers Market, Spain, Volume (Units), by Segment, 2018-2033 166

8.2.3 Immunochemistry Analyzers Market, Spain, Volume (Units), by Segment, 2018-2033 168

8.2.4 Point of Care (POC) Analyzers Market, Spain, Volume (Units), by Segment, 2018-2033 170

8.2.5 Polymerase Chain Reaction (PCR) Systems Market, Spain, Volume (Units), by Segment, 2018-2033 172

8.3 IVD Analyzers Market, Spain, Average Price ($) , 2018-2033 174

8.4 IVD Analyzers Market, Spain, Company Share by Revenue ($m), 2024 178

9 Overview of Key Companies in EU5 IVD Analyzers Market 180

9.1 F. Hoffmann-La Roche Ltd 180

9.1.1 Company Overview 180

9.2 Siemens Healthineers AG 180

9.2.1 Company Overview 180

9.3 Sysmex Corp 180

9.3.1 Company Overview 180

9.4 Abbott Laboratories 181

9.4.1 Company Overview 181

9.5 Danaher Corp 181

9.5.1 Company Overview 181

9.6 Bio-Rad Laboratories Inc 181

9.6.1 Company Overview 181

9.7 Horiba Ltd 181

9.7.1 Company Overview 181

9.8 Thermo Fisher Scientific Inc 182

9.8.1 Company Overview 182

9.9 DiaSorin SpA 182

9.9.1 Company Overview 182

9.10 bioMerieux SA 182

9.10.1 Company Overview 182

10 IVD Analyzers Market Pipeline Products 183

11 Recent Developments 207

11.1 Corporate Communications 207

11.1.1 Jun 03, 2025: SenzaGen Receives New Assignment From RIFM – Confirms Successful Expansion of Testing Portfolio 207

11.1.2 Sep 10, 2024: Qlife is to Announce that Peter Warthoe will Return to the Management Group as Chief Scientific Officer 207

11.2 Financial Announcements 208

11.2.1 May 23, 2025: Angle PLC: Notice of Results 208

11.2.2 Aug 06, 2024: MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance 208

11.2.3 Jul 30, 2024: SDI Group Reports Final Audited Results for Year Ended April 30, 2024 209

11.2.4 Jul 15, 2024: Boule Diagnostics – Invitation to Presentation of the Interim Report Q2 2024 210

11.2.5 Jul 05, 2024: CellaVision Report Invitation to Presentation for the Second Quarter 2024 on July 19, at 11:00 CEST 210

11.3 Legal And Regulatory 210

11.3.1 Jul 19, 2024: Qlife Holding Subsidiary Qlife APS Terminates Corporate Restructuring and Files for Bankruptcy. Qlife Holding Investigates a Capital Raise and to Submit an Offer to Repurchase the Assets 210

11.4 Other Significant Developments 211

11.4.1 Jun 04, 2025: ALIKO SCIENTIFIC Inks Exclusive Distribution Agreement With Menarini Diagnostics 211

11.4.2 Feb 05, 2025: UMC Utrecht Adopts Volta Labs Callisto Sample Prep System to Process Thousands of Samples for Whole Genome Sequencing-Based Prenatal and Postnatal Testing 211

11.4.3 Jan 30, 2025: Axsome Therapeutics Announces FDA Approval of SYMBRAVO (meloxicam and rizatriptan) for Acute Treatment of Migraine with or without Aura in Adults 212

11.4.4 Jan 07, 2025: Qlife Provides Update on Operational Progress in China 214

11.4.5 Dec 20, 2024: RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial 214

11.4.6 Oct 23, 2024: F. Hoffmann-La Roche Announces Third Quarter Sales 2024 215

11.4.7 Oct 08, 2024: NIHR Awards £30 Million to NHS to Buy Cutting Edge Research Equipment 215

11.4.8 Sep 04, 2024: Production Of Egoo Consumables Now Established In China To Support On-going Clinical Trials And Future Sales 216

11.5 Product News 216

11.5.1 Jun 04, 2025: Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse G STREM2 Assay for Research Use Only 216

11.5.2 Jan 16, 2025: Qlife Announces Introduction of a CE-Approved Joint Developed Egoo Health Platform for Immediate Sales 216

11.5.3 Nov 21, 2024: ArcticZymes' M-SAN HQ Sets New Standard for Measles Virus Purification with Unmatched DNA Clearance and High Recovery Rates 217

11.5.4 Sep 10, 2024: Merck Launches Single-Use Reactor Designed to Accelerate ADC Manufacturing 218

11.5.5 Aug 29, 2024: New Method Developed to Detect Fake Vaccines in Supply Chains 218

11.5.6 Aug 08, 2024: Genetic Analysis launches consumer microbiome testing platform through Prokarimi, powered by GA-map technology 219

11.6 Strategy And Business Planning 219

11.6.1 May 15, 2025: IMU Biosciences Adopts Curiox’s Pluto for Large-Scale UK Immune Profiling Initiative 219

11.6.2 May 13, 2025: Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics 220

11.6.3 Apr 25, 2025: Bioskryb Genomics and Tecan Introduce a Single-Cell Multiomics Workflow for Sequencing-Ready Libraries in Under Ten Hours 220

11.6.4 Feb 14, 2025: Qlife Launches Thyroid Disease and Vitamin D Biomarkers, Now Available for Immediate Sales 221

11.6.5 Oct 02, 2024: Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica to Advance the Discovery of Novel Drugs for Neurological Disease 221

11.6.6 Sep 23, 2024: Angle PLC Announces Exclusive Agreement for DNA NGS Panel 221

11.6.7 Sep 17, 2024: Progress Update: SUDPACK MEDICA’s French Site Expansion is on Schedule 222

11.6.8 Aug 08, 2024: Genetic Analysis launches consumer microbiome testing platform through Prokarimi, powered by GA-map technology 223

11.6.9 Jul 01, 2024: Artel Portfolio Expands Presence in Europe 224

12 Appendix 225

12.1 Research Methodology 226

12.1.1 Coverage 226

12.1.2 Secondary Research 226

12.1.3 Primary Research 226

12.1.4 Market Modeling and Forecasting 227

12.1.5 Company Share Analysis 228

12.1.6 Benchmarking 229

12.2 GlobalData Consulting 230

12.3 Contact Us 230

12.4 Disclaimer 230

Table

Table 1: IVD Analyzers Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033 15

Table 2: IVD Analyzers Market, EU5, Revenue ($m), USD Constant, 2018-2033 17

Table 3: IVD Analyzers Market, EU5, Volume (Units), 2018-2033 19

Table 4: IVD Analyzers Market, EU5, Volume (Units), 2018-2033 21

Table 5: IVD Analyzers Market, EU5, Company Share by Revenue ($m), 2024 23

Table 6: IVD Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 25

Table 7: Clinical Chemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 27

Table 8: Hematology Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 29

Table 9: Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 31

Table 10: Next Generation Sequencers Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 33

Table 11: Point of Care (POC) Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 35

Table 12: Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 37

Table 13: IVD Analyzers Market, United Kingdom, Volume (Units), 2018-2033 39

Table 14: Clinical Chemistry Analyzers Market, United Kingdom, Volume (Units), 2018-2033 42

Table 15: Hematology Analyzers Market, United Kingdom, Volume (Units), 2018-2033 44

Table 16: Immunochemistry Analyzers Market, United Kingdom, Volume (Units), 2018-2033 46

Table 17: Next Generation Sequencers Market, United Kingdom, Volume (Units), 2018-2033 48

Table 18: Point of Care (POC) Analyzers Market, United Kingdom, Volume (Units), 2018-2033 50

Table 19: Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Volume (Units), 2018-2033 52

Table 20: IVD Analyzers Market, United Kingdom, Average Price ($), 2018-2033 53

Table 21: IVD Analyzers Market, United Kingdom, Company Share by Revenue ($m), 2024 57

Table 22: IVD Analyzers Market, Germany, Revenue ($m), USD Constant, 2018-2033 59

Table 23: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, 2018-2033 61

Table 24: Hematology Analyzers Market, Germany, Revenue ($m), USD Constant, 2018-2033 63

Table 25: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, 2018-2033 65

Table 26: Next Generation Sequencers Market, Germany, Revenue ($m), USD Constant, 2018-2033 67

Table 27: Point of Care (POC) Analyzers Market, Germany, Revenue ($m), USD Constant, 2018-2033 69

Table 28: Polymerase Chain Reaction (PCR) Systems Market, Germany, Revenue ($m), USD Constant, 2018-2033 71

Table 29: IVD Analyzers Market, Germany, Volume (Units), 2018-2033 73

Table 30: Clinical Chemistry Analyzers Market, Germany, Volume (Units), 2018-2033 76

Table 31: Hematology Analyzers Market, Germany, Volume (Units), 2018-2033 78

Table 32: Immunochemistry Analyzers Market, Germany, Volume (Units), 2018-2033 80

Table 33: Next Generation Sequencers Market, Germany, Volume (Units), 2018-2033 82

Table 34: Point of Care (POC) Analyzers Market, Germany, Volume (Units), 2018-2033 84

Table 35: Polymerase Chain Reaction (PCR) Systems Market, Germany, Volume (Units), 2018-2033 86

Table 36: IVD Analyzers Market, Germany, Average Price ($), 2018-2033 87

Table 37: IVD Analyzers Market, Germany, Company Share by Revenue ($m), 2024 91

Table 38: IVD Analyzers Market, France, Revenue ($m), USD Constant, 2018-2033 93

Table 39: Clinical Chemistry Analyzers Market, France, Revenue ($m), USD Constant, 2018-2033 95

Table 40: Hematology Analyzers Market, France, Revenue ($m), USD Constant, 2018-2033 97

Table 41: Immunochemistry Analyzers Market, France, Revenue ($m), USD Constant, 2018-2033 99

Table 42: Point of Care (POC) Analyzers Market, France, Revenue ($m), USD Constant, 2018-2033 101

Table 43: Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), USD Constant, 2018-2033 103

Table 44: IVD Analyzers Market, France, Volume (Units), 2018-2033 105

Table 45: Clinical Chemistry Analyzers Market, France, Volume (Units), 2018-2033 107

Table 46: Hematology Analyzers Market, France, Volume (Units), 2018-2033 109

Table 47: Immunochemistry Analyzers Market, France, Volume (Units), 2018-2033 111

Table 48: Point of Care (POC) Analyzers Market, France, Volume (Units), 2018-2033 113

Table 49: Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), 2018-2033 115

Table 50: IVD Analyzers Market, France, Average Price ($), 2018-2033 116

Table 51: IVD Analyzers Market, France, Company Share by Revenue ($m), 2024 120

Table 52: IVD Analyzers Market, Italy, Revenue ($m), USD Constant, 2018-2033 122

Table 53: Clinical Chemistry Analyzers Market, Italy, Revenue ($m), USD Constant, 2018-2033 124

Table 54: Hematology Analyzers Market, Italy, Revenue ($m), USD Constant, 2018-2033 126

Table 55: Immunochemistry Analyzers Market, Italy, Revenue ($m), USD Constant, 2018-2033 128

Table 56: Point of Care (POC) Analyzers Market, Italy, Revenue ($m), USD Constant, 2018-2033 130

Table 57: Polymerase Chain Reaction (PCR) Systems Market, Italy, Revenue ($m), USD Constant, 2018-2033 132

Table 58: IVD Analyzers Market, Italy, Volume (Units), 2018-2033 134

Table 59: Clinical Chemistry Analyzers Market, Italy, Volume (Units), 2018-2033 136

Table 60: Hematology Analyzers Market, Italy, Volume (Units), 2018-2033 138

Table 61: Immunochemistry Analyzers Market, Italy, Volume (Units), 2018-2033 140

Table 62: Point of Care (POC) Analyzers Market, Italy, Volume (Units), 2018-2033 142

Table 63: Polymerase Chain Reaction (PCR) Systems Market, Italy, Volume (Units), 2018-2033 144

Table 64: IVD Analyzers Market, Italy, Average Price ($), 2018-2033 145

Table 65: IVD Analyzers Market, Italy, Company Share by Revenue ($m), 2024 149

Table 66: IVD Analyzers Market, Spain, Revenue ($m), USD Constant, 2018-2033 151

Table 67: Clinical Chemistry Analyzers Market, Spain, Revenue ($m), USD Constant, 2018-2033 153

Table 68: Hematology Analyzers Market, Spain, Revenue ($m), USD Constant, 2018-2033 155

Table 69: Immunochemistry Analyzers Market, Spain, Revenue ($m), USD Constant, 2018-2033 157

Table 70: Point of Care (POC) Analyzers Market, Spain, Revenue ($m), USD Constant, 2018-2033 159

Table 71: Polymerase Chain Reaction (PCR) Systems Market, Spain, Revenue ($m), USD Constant, 2018-2033 161

Table 72: IVD Analyzers Market, Spain, Volume (Units), 2018-2033 163

Table 73: Clinical Chemistry Analyzers Market, Spain, Volume (Units), 2018-2033 165

Table 74: Hematology Analyzers Market, Spain, Volume (Units), 2018-2033 167

Table 75: Immunochemistry Analyzers Market, Spain, Volume (Units), 2018-2033 169

Table 76: Point of Care (POC) Analyzers Market, Spain, Volume (Units), 2018-2033 171

Table 77: Polymerase Chain Reaction (PCR) Systems Market, Spain, Volume (Units), 2018-2033 173

Table 78: IVD Analyzers Market, Spain, Average Price ($), 2018-2033 174

Table 79: IVD Analyzers Market, Spain, Company Share by Revenue ($m), 2024 179

Table 80: IVD Analyzers Market Pipeline Products 183

Table 81: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 227

Figures

Figure 1: IVD Analyzers Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033 15

Figure 2: IVD Analyzers Market, EU5, Revenue ($m), USD Constant, 2018-2033 16

Figure 3: IVD Analyzers Market, EU5, Volume (Units), 2018-2033 19

Figure 4: IVD Analyzers Market, EU5, Volume (Units), 2018-2033 20

Figure 5: IVD Analyzers Market, EU5, Company Share (%), 2024 22

Figure 6: IVD Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 24

Figure 7: Clinical Chemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 26

Figure 8: Hematology Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 28

Figure 9: Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 30

Figure 10: Next Generation Sequencers Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 32

Figure 11: Point of Care (POC) Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 34

Figure 12: Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 36

Figure 13: IVD Analyzers Market, United Kingdom, Volume (Units), 2018-2033 38

Figure 14: Clinical Chemistry Analyzers Market, United Kingdom, Volume (Units), 2018-2033 41

Figure 15: Hematology Analyzers Market, United Kingdom, Volume (Units), 2018-2033 43

Figure 16: Immunochemistry Analyzers Market, United Kingdom, Volume (Units), 2018-2033 45

Figure 17: Next Generation Sequencers Market, United Kingdom, Volume (Units), 2018-2033 47

Figure 18: Point of Care (POC) Analyzers Market, United Kingdom, Volume (Units), 2018-2033 49

Figure 19: Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Volume (Units), 2018-2033 51

Figure 20: IVD Analyzers Market, United Kingdom, Company Share (%), 2024 56

Figure 21: IVD Analyzers Market, Germany, Revenue ($m), USD Constant, 2018-2033 58

Figure 22: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, 2018-2033 60

Figure 23: Hematology Analyzers Market, Germany, Revenue ($m), USD Constant, 2018-2033 62

Figure 24: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, 2018-2033 64

Figure 25: Next Generation Sequencers Market, Germany, Revenue ($m), USD Constant, 2018-2033 66

Figure 26: Point of Care (POC) Analyzers Market, Germany, Revenue ($m), USD Constant, 2018-2033 68

Figure 27: Polymerase Chain Reaction (PCR) Systems Market, Germany, Revenue ($m), USD Constant, 2018-2033 70

Figure 28: IVD Analyzers Market, Germany, Volume (Units), 2018-2033 72

Figure 29: Clinical Chemistry Analyzers Market, Germany, Volume (Units), 2018-2033 75

Figure 30: Hematology Analyzers Market, Germany, Volume (Units), 2018-2033 77

Figure 31: Immunochemistry Analyzers Market, Germany, Volume (Units), 2018-2033 79

Figure 32: Next Generation Sequencers Market, Germany, Volume (Units), 2018-2033 81

Figure 33: Point of Care (POC) Analyzers Market, Germany, Volume (Units), 2018-2033 83

Figure 34: Polymerase Chain Reaction (PCR) Systems Market, Germany, Volume (Units), 2018-2033 85

Figure 35: IVD Analyzers Market, Germany, Company Share (%), 2024 90

Figure 36: IVD Analyzers Market, France, Revenue ($m), USD Constant, 2018-2033 92

Figure 37: Clinical Chemistry Analyzers Market, France, Revenue ($m), USD Constant, 2018-2033 94

Figure 38: Hematology Analyzers Market, France, Revenue ($m), USD Constant, 2018-2033 96

Figure 39: Immunochemistry Analyzers Market, France, Revenue ($m), USD Constant, 2018-2033 98

Figure 40: Point of Care (POC) Analyzers Market, France, Revenue ($m), USD Constant, 2018-2033 100

Figure 41: Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), USD Constant, 2018-2033 102

Figure 42: IVD Analyzers Market, France, Volume (Units), 2018-2033 104

Figure 43: Clinical Chemistry Analyzers Market, France, Volume (Units), 2018-2033 106

Figure 44: Hematology Analyzers Market, France, Volume (Units), 2018-2033 108

Figure 45: Immunochemistry Analyzers Market, France, Volume (Units), 2018-2033 110

Figure 46: Point of Care (POC) Analyzers Market, France, Volume (Units), 2018-2033 112

Figure 47: Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), 2018-2033 114

Figure 48: IVD Analyzers Market, France, Company Share (%), 2024 119

Figure 49: IVD Analyzers Market, Italy, Revenue ($m), USD Constant, 2018-2033 121

Figure 50: Clinical Chemistry Analyzers Market, Italy, Revenue ($m), USD Constant, 2018-2033 123

Figure 51: Hematology Analyzers Market, Italy, Revenue ($m), USD Constant, 2018-2033 125

Figure 52: Immunochemistry Analyzers Market, Italy, Revenue ($m), USD Constant, 2018-2033 127

Figure 53: Point of Care (POC) Analyzers Market, Italy, Revenue ($m), USD Constant, 2018-2033 129

Figure 54: Polymerase Chain Reaction (PCR) Systems Market, Italy, Revenue ($m), USD Constant, 2018-2033 131

Figure 55: IVD Analyzers Market, Italy, Volume (Units), 2018-2033 133

Figure 56: Clinical Chemistry Analyzers Market, Italy, Volume (Units), 2018-2033 135

Figure 57: Hematology Analyzers Market, Italy, Volume (Units), 2018-2033 137

Figure 58: Immunochemistry Analyzers Market, Italy, Volume (Units), 2018-2033 139

Figure 59: Point of Care (POC) Analyzers Market, Italy, Volume (Units), 2018-2033 141

Figure 60: Polymerase Chain Reaction (PCR) Systems Market, Italy, Volume (Units), 2018-2033 143

Figure 61: IVD Analyzers Market, Italy, Company Share (%), 2024 148

Figure 62: IVD Analyzers Market, Spain, Revenue ($m), USD Constant, 2018-2033 150

Figure 63: Clinical Chemistry Analyzers Market, Spain, Revenue ($m), USD Constant, 2018-2033 152

Figure 64: Hematology Analyzers Market, Spain, Revenue ($m), USD Constant, 2018-2033 154

Figure 65: Immunochemistry Analyzers Market, Spain, Revenue ($m), USD Constant, 2018-2033 156

Figure 66: Point of Care (POC) Analyzers Market, Spain, Revenue ($m), USD Constant, 2018-2033 158

Figure 67: Polymerase Chain Reaction (PCR) Systems Market, Spain, Revenue ($m), USD Constant, 2018-2033 160

Figure 68: IVD Analyzers Market, Spain, Volume (Units), 2018-2033 162

Figure 69: Clinical Chemistry Analyzers Market, Spain, Volume (Units), 2018-2033 164

Figure 70: Hematology Analyzers Market, Spain, Volume (Units), 2018-2033 166

Figure 71: Immunochemistry Analyzers Market, Spain, Volume (Units), 2018-2033 168

Figure 72: Point of Care (POC) Analyzers Market, Spain, Volume (Units), 2018-2033 170

Figure 73: Polymerase Chain Reaction (PCR) Systems Market, Spain, Volume (Units), 2018-2033 172

Figure 74: IVD Analyzers Market, Spain, Company Share (%), 2024 178

EU5 IVD Analyzers Market Outlook to 2033: Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others standard reports
Currency USD
$5,995

Can be used by individual purchaser only

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at EU5 IVD Analyzers Market Outlook to 2033: Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others in real time.

  • Access a live EU5 IVD Analyzers Market Outlook to 2033: Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.